Related Experiment Video

Updated: Sep 23, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p

Naoki Mori1, Roberta Morosetti, Hideaki Mizoguchi

  • 1Department of Medicine, Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA.

British Journal of Haematology
|July 9, 2003
PubMed

Insights

Loss of heterozygosity on chromosome 1p occurs in 30% of myelodysplastic syndrome (MDS) patients progressing to acute myeloid leukemia (AML), suggesting tumor suppressor genes in this region drive disease progression.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndrome (MDS) is a stem cell neoplasm.
  • One-third of MDS patients progress to acute myeloid leukemia (AML).
  • Mechanisms driving MDS to AML progression are poorly understood.

Purpose of the Study:

  • To investigate allelic loss on chromosome 1p during MDS progression to AML.
  • To identify potential tumor suppressor genes involved in MDS to AML transformation.

Main Methods:

  • Examined 20 patients with progression from MDS to AML.
  • Utilized 17 microsatellite markers spanning chromosome 1.
  • Analyzed DNA from bone marrow smears of both MDS and AML stages.

Main Results:

  • Allelic loss on chromosome 1p was detected in 30% (6/20) of patients.
  • Loss of heterozygosity (LOH) was observed in specific regions of 1p (1p36.3 and 1p32-).
  • Serial cytogenetic data did not reveal deletions in these patients.

Conclusions:

  • Tumor suppressor genes crucial for MDS to AML progression may be located on chromosome 1p.
  • At least two distinct regions on 1p are implicated in this process.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...